Double Blind Dose - Escalation, Randomized, Controlled, Phase I-II Trial to Evaluate Safety and Immunogenicity of Three Doses of Sabin-IPV and Adjuvanted Sabin-IPV in Healthy Infants

Trial Profile

Double Blind Dose - Escalation, Randomized, Controlled, Phase I-II Trial to Evaluate Safety and Immunogenicity of Three Doses of Sabin-IPV and Adjuvanted Sabin-IPV in Healthy Infants

Completed
Phase of Trial: Phase I/II

Latest Information Update: 17 Jul 2014

At a glance

  • Drugs Poliovirus vaccine Intravacc/WHO (Primary) ; Aluminium hydroxide; Poliovirus vaccine inactivated
  • Indications Poliomyelitis
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Feb 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 09 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top